文章摘要
李爱花,任慧玲,张玢.基于文献计量的新型冠状病毒肺炎研究现状分析[J].数字图书馆论坛,2020,(3):2~8
基于文献计量的新型冠状病毒肺炎研究现状分析
COVID-19 Research Status Based on Bibliometrics
投稿时间:2020-03-22  
DOI:10.3772/j.issn.1673-2286.2020.03.001
中文关键词: 新型冠状病毒肺炎;文献计量;研究现状
英文关键词: COVID-19; Bibiometrics; Research Status
基金项目:本研究得到北京协和医学院学科建设项目“北京协和医学院排名提升策略研究”(编号:201920101102)和中国医学科学院医学与健康科技创新工程协同创新团队项目(编号:17C003-1)资助。
作者单位
李爱花 中国医学科学院医学信息研究所 
任慧玲 中国医学科学院医学信息研究所 
张玢 中国医学科学院医学信息研究所 
摘要点击次数: 1258
全文下载次数: 800
中文摘要:
      2019年12月新型冠状病毒肺炎疫情发生以来,国内外研究文献快速增长。截至2020年3月20日,PubMed/SinoMed数据库已收录全球正式发表的新型冠状病毒肺炎文献3?086篇,生物医学预印本平台BioRxiv/MedRxiv共发表文献701篇。本文分别从中英文文献的期刊来源、出版时间、作者机构、研究热点等方面进行文献计量分析。结果表明:①目前正式发表的新型冠状病毒肺炎研究文献,中文文献占59%,中国大陆发表的文献占全球文献总数的78%(含合作发表文献);华中科技大学和武汉大学是中英文文献产出最多的机构;美国、英国占发文总量的第二、第三位。②中文文献在中医药治疗、社区/人群防控等领域具有优势,体现中国疫情防控中西医结合、群防群治的特点;而英文文献中关于病毒溯源,检验、检测等领域的报道较多。建议更多重要文献在以英文发表的同时也能同步或尽早在中文期刊发表。
英文摘要:
      Since the outbreak of COVID-19 in December 2019, the research literature has increased rapidly. Up to March 20, 2020, there have been 3?086 scientific literatures on COVID-19 published in the PubMed and SinoMed database, and 701 in the biomedical preprint platform BioRxiv/MedRxiv. In this paper, we make a bibliometric analysis of Chinese and English literature from the perspectives of journal source, publication time, author organization and research focus. Results: ①At present, Chinese literature accounts for 59% of the total number of related literature, and mainland China contributed for 78% of the total literature (including co-authored literature), followed by the United States and the United Kingdom. Huazhong University of Science and Technology and Wuhan University are the institutions with the largest output of Chinese and English literature; ②The research content of Chinese literature focuses on the fields of traditional Chinese medicine treatment, community / population epidemic prevention and control, reflecting the advantages of the combination of Chinese and Western medicine in epidemic prevention and control; however, the literature on virus tracing, detection methods, drug and vaccine development are mainly published in English journals, and relatively less published in Chinese journals. It is suggested that when we are actively publishing our research in English journals, we also need to pay more attention to publish important results to Chinese journals and share them in our own mother language.
查看全文   查看/发表评论  下载PDF阅读器
关闭

分享按钮